6 8 3 a r t I C l e S During neural development, the axon and dendrites of each neuron are confronted with a difficult task: finding the appropriate synaptic partners among a sea of inappropriate ones to form a functional neural circuit. In the past two decades, the molecular mechanisms of axon targeting have been intensively studied. Although axon guidance and target selection are classically believed to dominate neural circuit formation, active dendrite processes are also indispensable for proper patterning. For example, vertebrate retinal ganglion cells target their dendrites to specific laminar layers to make synaptic connections with bipolar and amacrine cells 1 . In addition, oriented dendrite patterning of mouse motor neurons is actively regulated by the expression of the ETS transcription factor Pea3, which is itself induced by sensory stimuli 2 . Relatively little is known in general, however, about the molecular mechanisms of dendrite targeting.
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The Drosophila olfactory system provides an excellent opportunity to examine the molecular mechanisms that underlie both dendrite and axon targeting 3, 4 . In the adult antennal lobe, axons of ~50 classes of olfactory receptor neurons (ORNs) and dendrites of ~50 classes of second-order projection neurons typically target one of ~50 glomeruli, forming one-to-one precise connections (Fig. 1a) . The target glomerulus of each projection neuron dendrite is pre-specified by birth order and the intrinsic activity of transcription factors 4, 5 . Projection neuron dendrite targeting occurs before invasion of the antennal lobe by presynaptic ORN axons, suggesting an independent regulation of both processes 6 . During the initial coarse targeting, developing projection neuron dendrites express a gradient of Semaphorin-1a (Sema-1a), which acts as a receptor for potential ligands Sema-2a and Sema-2b, along the dorsolateral-to-ventromedial axis in the antennal lobe 7, 8 . After the coarse targeting, synaptic partner matching and refinement of each class of projection neuron dendrites are carried out by the activity of various cell-surface transmembrane molecules, such as DN-Cadherin, Capricious, Dscam and the Teneurins [9] [10] [11] [12] . Thus, previous studies have revealed the coordinated interconnection of multiple cell surface molecules.
As the vast majority of proteins used for the target recognition in dendrites are secretory and cell surface proteins, their folding and initial glycosylation occur in the ER. To assist the maturation of proteins, the lumen of the ER provides access to numerous enzymes and chaperones. In addition, chaperones such as calreticulin and calnexin provide a quality control mechanism that ensures only correctly folded proteins are released by transient binding through the N-glycan that is attached to newly synthesized protein. Thus, the capacity to produce the mature proteins at the ER (hereafter referred to as ER folding capacity) greatly depends on the cell condition, particularly the expression level and combination of various enzymes, chaperones and components of the N-glycosylation machinery 13, 14 . If the translation of secretory proteins exceeds the ER folding capacity, the overload of unfolded protein at the ER induces an evolutionarily conserved signal transduction mechanism, the so called unfolded protein response (UPR) 15 . As a consequence of the UPR, general translation is attenuated, the expression of enzymes, chaperones and N-glycosylation-related genes are upregulated, and the ER-associated degradation system to eliminate the unfolded proteins is activated 16 . Although the UPR is thought to act especially in pathological conditions, it is also essential for normal development 17, 18 . However, it is still unclear how ER folding capacity and the UPR are managed in developing neurons, which require both a large amount and variety of functional transmembrane and secreted proteins.
a r t I C l e S
We isolated and characterized Meigo, an evolutionarily conserved protein that is required for the precise targeting of projection neuron dendrites and ORN axons in the Drosophila olfactory system. Meigo is the Drosophila homolog of SLC35B1, an ER-resident protein that belongs to the nucleotide sugar transporter family 19 . Loss of Meigo induced UPR in projection neuron dendrites, which led to a decrease in the amount of cell surface proteins, including Ephrin. Biochemical analyses revealed that Meigo promoted the proper N-glycosylation and cell surface localization of Ephrin, which, in part, mediated Meigo's in vivo function. We propose that Meigo enhances the ER folding capacity by contributing to the N-glycosylation machinery, ensuring the production of multiple cell surface proteins that are required for dendrite and axon targeting.
RESULTS

meigo is required in projection neurons for dendrite targeting
To identify genes that regulate neuronal targeting specificity, we performed a mosaic analysis with a repressive cell marker (MARCM)-based genetic mosaic screen in projection neurons 20 and isolated a dendrite targeting mutant, meigo 1 (medial glomeruli, 'lost child' in Japanese). In MARCM anterodorsal neuroblast clones homozygous for meigo 1 in an otherwise heterozygous background, the meigo 1 projection neurons labeled with the projection neuron driver GH146-Gal4 exhibited improper medial shift of dendrite targeting in the antennal lobe (Fig. 1b,c) . Using the Mz19-Gal4 driver, which labels a small subset of projection neurons, dendrites that normally target the laterally located glomeruli (VA1d and DC3) also shifted medially (Fig. 1c) . In contrast, projection neurons labeled by the NP5103-Gal4 driver 21 , which normally target the medial glomerulus VM2, still targeted properly, with a glomerular spillover (46%, n = 13; Fig. 1c) . Quantification of these dendrite distributions revealed that, although lateral meigo 1 dendrites were significantly shifted medially (P < 0.025), they retained their normal position along the orthogonal dorsoventral axis (Fig. 1d) . This was also observed in neuroblast clones of the lateral lineage ( Supplementary Fig. 1a,b) . This phenotype was already evident at early pupal stages (16 h after puparium formation), when initial projection neuron targeting occurs (Supplementary Fig. 1c) , suggesting that the initial dendrite targeting to the proto-antennal lobe is defective in meigo 1 projection neurons.
To analyze projection neuron dendrite targeting with higher resolution, we generated meigo 1 projection neuron single-cell clones whose dendrites, in wild-type neurons, target the DL1 glomerulus. As with meigo 1 neuroblast clones, the majority of meigo 1 DL1 projection neuron (Fig. 2a) . The quantification of axon innervation in the antennal lobe revealed that meigo 1 ORN axons also exhibited a significant medial shift in their glomerular targeting (P < 0.001), similar to mutant projection neuron dendrites (Fig. 2b) . Together with our projection neuron analysis ( Fig. 1) , these data indicate that meigo is independently required in projection neurons and ORNs for lateral targeting of their dendrites and axons, respectively. This suggests that projection neurons and ORNs utilize shared positional signal(s) along the mediolateral axis of the antennal lobe to reach target glomeruli. The meigo 1 mutation likely disrupts the recognition of this putative mediolateral positional signal(s) in the antennal lobe. meigo encodes a highly conserved ER protein We mapped meigo 1 to a missense mutation in CG5802, encoding an evolutionarily conserved protein, at a residue conserved from fly to human (67.5% similar to yeast hut1, 81.2% to C. elegans hut1, 81.0% to mouse UGTrel1 (also known as Slc35b1) and 80.7% to human UGTrel1 (also known as SLC35B1); Supplementary Fig. 2a ). To confirm that this is the causative mutation for the meigo phenotype, we created a deletion that removed the N-terminal half of the predicted CG5802 protein (CG5802 del ; Supplementary Fig. 2a) . We found that CG5802 del projection neuron clones exhibited the same dendrite mistargeting as meigo 1 projection neuron clones (Supplementary Fig. 2b ). In addition, MARCM expression of the CG5802 cDNA rescued the phenotype of meigo 1 projection neuron neuroblast and single-cell clones (Supplementary Fig. 2c ). These results indicate that meigo corresponds to CG5802. Furthermore, as GH146-Gal4 is only expressed in postmitotic projection neurons, these results suggest that Meigo is required both cell autonomously and postmitotically in projection neuron dendrite targeting. The phenotype of meigo 1 ORN clones was also rescued by the pebbled-GAL4-mediated transgenic expression of CG5802 and meigo cDNA in those clones (Supplementary Fig. 2c ).
meigo encodes a transmembrane protein with a KKXX ER retention motif near the C terminus that is conserved from yeast to human ( Fig. 3a and Supplementary Fig. 2d ). Consistently, both endogenous ( Fig. 3b) and transiently overexpressed ( Supplementary  Fig. 3a ) Meigo in Drosophila S2 cells decorated an ER-like membranous structure. To confirm the ER localization of Meigo, we used OptiPrep density centrifugation 25 to isolate membrane fractions of the ER and Golgi apparatus. Meigo was predominantly accumulated in the fractions that contained Hsc3, an ER-resident chaperone (also known as GRP78/BiP; Fig. 3c ). Lava Lamp (Lva) 26 , a marker of Golgi apparatus was found in fractions that are slightly overlapped with, but were clearly different from, those of Meigo (Fig. 3c) . These immunohistochemical and biochemical data indicate that Meigo is mainly localized at the ER.
Meigo is a unique nucleotide sugar transporter
Meigo is a predicted ortholog of human UGTrel1 (ref. 23) , the nucleotide sugar transporter (NST) that transports nucleotide sugars from the cytoplasm to the lumens of the ER 27 , an essential step for proper protein glycosylation. To test whether defects in NST can generally cause projection neuron mistargeting, we generated MARCM projection neuron clones for the other NST mutants (Fig. 3d) . fringe connection (frc) and slalom (sll) encode UDP-sugar and 3′-phosphate 5′-phosphosulfate transporters, respectively [28] [29] [30] . Notably, frc RY34 or sll 24533 projection neuron clones did not exhibit any targeting defects ( Supplementary Fig. 3b ). In addition, MARCM overexpression of frc, sll or ER GDP-fucose transporter (Efr) 31 in meigo 1 projection neuron clones could not suppress the dendrite targeting defect (Fig. 3e) , indicating that Meigo cannot be substituted for by other NSTs.
To examine the importance of glycosylation for projection neuron dendrite targeting, we examined mutations in several glycosyltransferases. We found that mutant MARCM clones of glycosyltransferases necessary for the mucin-type O-glycan 32 , sialylated carbohydrates 33 , heparan sulfate proteoglycans and chondroitin sulfate proteoglycans [34] [35] [36] D231S or ninaE G69D in wild-type (+) single-cell clones had either a weak effect or no effect; however, expression in meigo 1 (1) single-cell clones enhanced the targeting defect, suggesting that mutation of meigo enhances sensitivity to the ER stress. npg a r t I C l e S ER stress by expressing ninaE G69D , which encodes a mutant form of Rhodopsin-1 (Rh-1 G69D ) 16 . As above, MARCM expression of Hsc3 K97S , Hsc3 D231S or ninaE G69D by GH146-Gal4 had a mild effect on wild-type projection neuron dendrite targeting, but substantially enhanced dendrite mistargeting in meigo 1 neurons ( Fig. 4e; phenotype criteria in Fig. 1e ). These findings suggest that wild-type projection neurons are capable of managing these artificial ER stress, whereas meigo 1 projection neurons are vulnerable to ER stress, probably as a result of the reduced ER folding capacity.
ephrin genetically interacts with meigo Why does the meigo abrogation associated with UPR cause such a specific targeting defect in projection neuron dendrites? We hypothesized that the functions of particular cell surface proteins governing projection neuron dendrite targeting are weakened in meigo 1 projection neuron clones. To identify the hypothesized cell surface protein whose function is impaired in meigo 1 projection neurons, we performed a genetic suppressor screen for projection neuron dendrite targeting and identified ephrin (Supplementary Table 2 ). Overexpression of ephrin specifically and substantially suppressed the dendrite refinement defect of meigo 1 DL1 projection neuron single-cell clones (Fig. 5a) . Notably, only the 'mild mistargeting class' , the dendrite spillover from DL1 glomerulus, was suppressed, whereas the 'severe mistargeting class' (Fig. 1e) was mostly unchanged (Fig. 5a) . In contrast, overexpression of other genes, including sema-1a, DN-cadherin and hut1 inactivation induces chronic UPR and a defect in the maintenance of ER structure, resulting in early developmental lethality 19 . On the contrary, in cultured cells, ER stress induced by dithiothreitol leads to upregulation of meigo 39 and the human homolog UGTrel1 (ref. 40) . Thus, Meigo could represent a conserved aspect of the UPR. To examine whether loss of Meigo causes a UPR in Drosophila, we generated double-stranded RNA against meigo (meigo dsRNA) to knockdown its endogenous expression in S2 cells. To detect UPR, we simultaneously expressed an xbp1-EGFP construct whose mRNA is unconventionally spliced following UPR, producing a fluorescent fusion protein 16, 41 . Following application of meigo dsRNA (but not control dsRNA for chloramphenicol acetyltransferase (cat) of E. coli.), we detected the Xbp1-EGFP fusion protein, indicating the presence of a UPR (Fig. 4a) . We also detected a significant increase in mRNA for hsc3 (the Drosophila BiP) and pdi in S2 cells treated with meigo dsRNAs (P < 0.05; Fig. 4b) . Furthermore, when xbp1-egfp was overexpressed in meigo 1 projection neuron MARCM clones, the Xbp1-EGFP fusion protein was found in the nuclei (Fig. 4c) , revealing a similarity between the in vivo and cell culture responses. The nuclear localization of Xbp1-EGFP reflects the fact that the Xbp1 protein is a transcription factor 16 . Notably, we also observed the upregulation of the ER chaperone Hsc3 in the dendrites of meigo 1 projection neurons (Fig. 4d) , suggesting that the UPR occurs not only in the cell body, but also in the dendrites locally.
Our finding that loss of Meigo induces a UPR suggests that the ER folding capacity is reduced in meigo 1 projection neurons. To confirm this, we reduced ER folding capacity by expressing a dominantnegative form of Hsc3 (Hsc3 K97S , Hsc3 D231S ) 42 or further induced npg a r t I C l e S Dscam, which are required for projection neuron dendrite targeting 7,9,11 , did not suppress the dendrite refinement defect or targeting defect of meigo 1 DL1 projection neurons ( Fig. 5a and Supplementary Table 2 ). The overexpression of Eph in the meigo 1 projection neuron enhanced the severity of the phenotype (Fig. 5a) , suggesting that Eph-ephrin signaling contributes to the dendrite targeting and glomerular refinement of projection neuron.
Next, we tested whether Meigo can affect the amount of cell surface molecules that are expressed, including Ephrin. As we could not monitor endogenous Ephrin in projection neurons, owing to a lack of appropriate reagents, we quantified the expression of transfected Ephrin:myc, Sema-1a or DN-Cadherin 43 in control and meigo dsRNA-treated S2 cells. We detected, to different degrees, significant reductions in the expression of Ephrin-myc (P < 0.025), Sema-1a (P < 0.05) and DN-Cadherin (P < 0.05) proteins in meigo dsRNAtreated S2 cells compared with nontreated S2 cells ( Fig. 5b and  Supplementary Fig. 3c,d) . Furthermore, the subcellular localization of Ephrin was also affected in meigo dsRNA-treated S2 cells (Fig. 5c) . The ratio of cells with Ephrin-myc present at the plasma membrane was substantially decreased by knockdown of meigo, whereas the cell surface localization of Ephrin-myc was promoted in cells overexpressing meigo (Fig. 5c) . These genetic and biochemical data suggest that dendrite targeting defect in meigo 1 projection neurons seems to be, at least in part, a result of the reduction of Ephrin protein at the plasma membrane.
Ephrin is essential for glomerular refinement of dendrites
The Drosophila ephrin gene is located on the fourth chromosome, which prevented us from performing mutant MARCM analysis. To examine the requirement of ephrin in projection neuron dendrite targeting, we used MARCM to express short-hairpin RNA 44 for ephrin (ephrin shRNA; Supplementary Fig. 4a-d) . The anterodorsal neuroblast projection neuron clones expressing ephrin shRNA (Fig. 5d) exhibited dendrite spillover, which was rescued by the expression of shRNA-resistant ephrin (UAS-ephrin resistant ; Supplementary Fig. 4e) . We did not find preferential direction of the dendrite spillover, and the severity and penetrance of spillover seemed to be different between projection neuron classes ( Fig. 5d and data not shown) .
To analyze the dendrite defects in more detail, we analyzed single-cell clones of projection neurons innervating DL1 and neuroblast projection neuron clones innervating VM2. Notably, dendrites of DL1 or VM2 projection neurons expressing ephrin shRNA exhibited a spillover phenotype (Fig. 5d) , which mimicked that of meigo 1 projection neurons (NP5103-Gal4; Fig. 1c) . Thus, Ephrin is indeed essential in projection neuron dendrites for their proper refinement into the glomerulus, which is a part of the phenotype of meigo 1 projection neuron.
Meigo contributes to N-glycosylation of Ephrin
As Meigo is a putative NST that is required for the efficient production of cell surface molecules ( Fig. 5b and Supplementary  Fig. 3c,d) , we expected that Meigo might regulate ER folding capacity through glycosylation machinery in the ER 45 . To examine this possibility, we analyzed the glycosylation of one of the target proteins, Ephrin. Ephrins are reported to have conserved N-glycosylation sites between family members and species, and the N-glycosylation of mouse Ephrin has been reported in vivo 46 . However, the role of N-glycosylation of the Ephrin protein has not yet been characterized. For the Drosophila Ephrin, the NetOGlyc 3.1 (http://www.cbs. dtu.dk/services/NetOGlyc/) and NetNGlyc 3.1 (http://www.cbs.dtu. dk/services/NetNGlyc/) servers predicted no site for O-glycosylation and four potential sites (Asn-222, Asn-265, Asn-274 and Asn-365) for N-glycosylation (Fig. 6a) . We confirmed that these sites were indeed N-glycosylated. Western blotting analysis with cell lysate extracted from S2 cells expressing Ephrin-myc showed four bands around 60 to 70 kDa (Fig. 6b) . Treatment of cell extracts with the N-glycosydase PNGaseF resulted in the band shift to the smallest molecular weight of about 60 kDa (Fig. 6b) , and mutagenesis of each potential N-glycosylation site caused the absence of the highest molecular weight band (Supplementary Fig. 5 ). Mutation of all putative N-glycosylation sites (Ephrin NQ ) resulted in a single band that was approximately the same molecular weight as seen after PNGaseF treatment (Fig. 6b) , suggesting that Ephrin is N-glycosylated and that the four bands of Ephrinmyc correspond to the N-glysosylation state of Ephrin-myc.
Next, we examined whether Meigo is required for N-glycosylation of Ephrin in S2 cells. We transiently expressed ephrin-myc in meigo dsRNA-treated S2 cells and analyzed the N-glycosylation state of Ephrin-myc. We reproducibly detected that the relative amount of the fully N-glycosylated form (N-Gly4) of Ephrin-myc (band at the a r t I C l e S highest molecular weight) was significantly reduced in S2 cells treated with meigo dsRNA compared with those treated with control dsRNA (P < 0.001; Fig. 6c,d) . In contrast, overexpression of meigo resulted in a significant increase in the amount of N-glycosylation of Ephrin-myc (P < 0.01; Fig. 6c,d) . These results indicate that Meigo positively affects the N-glycosylation state of Ephrin.
Finally, to examine the effect of N-glycosylation on signaling ability, we used a transgene expressing a form of Ephrin in which all of the N-glycosylation sites were mutated, UAS-ephrin NQ -myc. We found that Ephin NQ -myc could not suppress the dendrite refinement defect of meigo 1 projection neurons (Fig. 6e) , suggesting that N-glycosylation of Ephrin is crucial for its effective function in vivo. Thus, Meigomediated N-glycosylation is required for the effective function of Ephrin in vivo.
DISCUSSION Possible functions of Meigo in neuronal targeting
The loss-of-function meigo phenotype suggests that meigo has two functions in the projection neuron: dendrite targeting along the mediolateral axis of the antennal lobe and refinement of dendrites of individual projection neurons into single glomerulus. We propose that Meigo-mediated ER folding capacity is required for the spatiotemporal expression and function of various cell surface molecules (Supplementary Fig. 6 ). Among such molecules, however, only some may be susceptible to the reduction of ER folding capacity, accounting for the exquisitely specific phenotype of meigo 1 projection neurons and ORNs. We identified Ephrin as one such receptor that regulates the glomerular refinement of projection neuron dendrites. In the dendrites of meigo 1 projection neuron, Ephrin protein level was reduced, it was not localized to the cell surface efficiently and it was not fully N-glycosylated, all of which would cause the impairment of Ephrin function (Supplementary Fig. 6 ). The dendrite targeting defect along the mediolateral axis of meigo 1 projection neurons is not a consequence of the refinement defect, as ephrin overexpression was able to suppress mild, but not severe, phenotypes, and projection neurons expressing ephrin shRNA exhibited only the refinement defect. The effector molecule(s) that regulate dendrite and axon targeting along the mediolateral axis require future investigation. In summary, our results provide an unexpected link between Meigo as a regulator of ER folding capacity, Ephrin function and neuronal targeting specificity.
Consistent with previous studies of meigo homologs, we found that Drosophila Meigo strongly contributed to the UPR in cultured cells and in vivo. In addition, we also found that the putative NST Meigo positively regulated the N-glycosylation state of Ephrin, one of the target molecules. Because N-glycan is important for protein folding and quality control, the impairment of N-glycan synthesis often causes a UPR 45 . Although we could not exclude the possibility that Meigo directly contributes to the protein folding process, the mutant MARCM clones for ero1l, which is important for disulfide bond formation 47 , did not exhibit the same dendrite targeting defect as meigo. Thus, it is reasonable to speculate that Meigo is primarily required for an aspect of protein N-glycosylation, and Meigo knockdown results in less ER folding capacity, accompanied by a UPR.
How does Meigo contribute to protein N-glycosylation? One possible function is UDP-glucose transporter activity, as with the plant ortholog 48 , which can be linked to the glucosylation of N-glycan. As glucose is thought to be supplied from glucose phosphate dolichol in the ER for the glucosylation of N-glycan, this possibility also affects the glycobiological field. The other possibilities are that Meigo may function in core N-glycan synthesis or in translocation to the nascent polypeptides. Given that the mutant MARCM projection neuron clone for DSiaT exhibited the dendrite spillover phenotype, the sialylation of N-glycan might be important for the glomerular refinement 33 . In each case, further biochemical studies are required to reveal the precise molecular function of Meigo.
Neural targeting requires proper ER folding capacity
Precise neural circuit assembly is achieved by the combinatorial and sequential use of cell surface receptors and ligands, which are largely synthesized and folded in the ER. Thus, a proper folding capacity of the ER is critical for neural circuit formation, but the in vivo regulation of such has not been investigated. Using genetic mosaic methods, we found that induction of ER stress solely in the wild-type projection neurons did not cause dendrite mistargeting. This suggests that ER folding capacity is large enough and/or the UPR works efficiently enough to overcome ER stress without disturbing the function of cell surface receptors and ligands. On the other hand, the specific targeting defect observed in meigo 1 mosaic clones accompanied by a UPR was heightened by the further enhancement of ER stress. Thus, we present a broadly applicable hypothesis: Meigo-mediated ER folding capacity affects proteins involved in neural wiring. When meigo is absent, the ER folding capacity is reduced so that the translational attenuation through the UPR occurs severely. Meigo can provide unique inroads to investigate the unanticipated role of ER homeostasis in neural circuit formation.
Facilitation of Ephrin function by Meigo
Our genetic data suggest that, at least in projection neuron dendrites, Ephrin is involved in the refinement into the proper glomeruli. Ephrin has been implicated in axon target selection in mammalian olfactory system 49 . We found that Ephrin was also required for dendrite targeting. In addition, our results provide evidence that Meigo-mediated N-glycosylation of Ephrin is likely to be important for its function in vivo.
Although we cannot completely rule out the possibility that Meigo and Ephrin independently contribute to dendrite targeting specificity, several lines of evidence support the notion that Meigo promotes the Ephrin signal for dendrite refinement. First, meigo and ephrin exhibited strong genetic interactions in projection neuron dendrite targeting. Second, both meigo 1 projection neurons and ephrin shRNA-expressing projection neurons exhibited a similar phenotype in respect to dendrite spillover. Third, as Ephrin is a transmembrane protein, it is presumed to pass through the ER, where Meigo functions. Indeed, meigo knockdown in S2 cells led to a substantial reduction in Ephrin protein level, impairment of cell surface transport and reduced N-glycosylation state, indicating that Meigo is required for the efficient function of Ephrin proteins.
Why was the dendrite refinement defect of meigo 1 projection neuron specifically suppressed by ephrin overexpression? One possibility is that the Ephrin protein is highly sensitive to ER status. The UPR in meigo 1 projection neurons is unlikely to be prohibitively severe because the axonal morphology and size of meigo 1 neuroblast clones were largely normal (data not shown). Thus, such a mild ER stress may sufficiently affect the function of ER stress-sensitive proteins such as Ephrin, but not that of other transmembrane proteins. This is consistent with the fact that meigo 1 projection neurons are apparently sensitized to ER stress caused by ninaE G69D or dominant-negative Hsc3 overexpression. The other possibility is that the N-glycosylation modulated by Meigo might be critical for Ephrin compared with the other cell surface molecules. To the best of our knowledge, our results provide the first evidence that N-glycosylation of Ephrin is important for its function in vivo. npg a r t I C l e S Synaptic partners detect mediolateral axis independently Coarse targeting of adult projection neuron dendrites along the dorsolateral to ventromedial axis of the antennal lobe is partially determined by the projection neuron receptor Sema-1a detecting Sema-2a/b 7, 8 . No additional axis in the antennal lobe for constructing the local olfactory circuit has been identified. In this study, we found that dendrites of meigo 1 projection neurons and axons of meigo 1 ORNs exhibited medial mistargeting in the antennal lobe. Furthermore, Meigo, an ER protein, modulated targeting along the mediolateral axis. Thus, our findings confirm and strengthen the concept that the wiring of local neural circuits is based on the positional information conveyed along several body axes. Moreover, these results provide substantial advances toward understanding the mechanisms of neural circuit formation in a three-dimensional brain structure. Note that the dendrite refinement defect observed in ephrin shRNA-expressing projection neurons is similar to a part of the phenotype of meigo 1 projection neuron. This suggests that the regulation of Ephrin signal is only a part of Meigo's role in the dendrite morphogenesis; additional cell-surface molecules may account for Meigo-mediated mediolateral targeting of projection neuron dendrites and ORN axons.
To find their proper target, dendrites utilize receptors to recognize the cellular environments. Thus, it is reasonable that partners of presynaptic axons and postsynaptic dendrites share common molecules for targeting a shared destination. However, there has been no evidence that a common molecular mechanism is used independently by synaptic partners. Our data indicate that synaptic partners independently require the same molecule, Meigo, for their precise targeting. This is distinct from the Teneurins, which serve as synaptic partners, matching molecules by promoting projection neuron-ORN recognition 12, 50 . Instead, Meigo likely mediates a coarse targeting process to bring partner projection neurons and ORNs to the same vicinity independently. This is then followed by a synaptic matching process mediated by molecules such as the Teneurins.
In summary, we found that neurite targeting to precise target regions is achieved by an analogous mechanism in both pre-and postsynaptic partners through recognition of mediolateral axial information and refinement into each glomerulus. Meigo seems to be required for enhancing the ER folding capacity, possibly through the N-glycosylation machinery. The efficient expression, cell surface transport and N-glycosylation of Ephrin were promoted by Meigo. Further investigation of the physiological function of Meigo and its contribution to the Ephrin signal will shed light on the regulatory mechanism for Ephrin function in the ER during neural circuit formation.
METhODS
Methods and any associated references are available in the online version of the paper.
ONLINE METhODS
Fly strains. 32, 6 , Hs6st d770 , FRT 82B dar3(sar1) 11-3-6 Immunostaining. MARCM and brain immunostaining of both genders were performed as described 51, 52 . Both genders of adult flies younger than 7 d were used. S2 cells (1 × 10 5 ) were grown for 2 h at 26 °C on coverslips, and were fixed for 20 min in 4% paraformaldehyde (wt/vol) with 0.3% Triton X-100 (vol/vol) in phosphate-buffered saline (PBST), and rinsed in PBST. Cells were subsequently blocked in PBST with 5% normal goat serum (vol/vol) for 30 min. Primary and secondary antibody incubation were carried out in blocking solution for 1 h at 20-25 °C, with three 10-min washes in PBST after each incubation. For antibodies, we used rat antibody to Meigo (1:250), rat antibody to mCD8 (1:100, Invitrogen, MCD0800), mouse antibody to Bruchpilot (1:100, Developmental Studies Hybridoma Bank (DSHB), nc82), rat antibody to DN-cadherin (1:40, DSHB, DNEX-8), rat antibody to dGLG1 (120 kDa) 53 (1:20, a gift from S. Goto, Rikkyo University), mouse antibody to KDEL (1:100, Stressgen, SPA-827), mouse antibody to Pdi (1:1,000, StressGen, SA-891), mouse antibody to GFP (1:1,000, Clontech, 632381), rabbit antibody to Hsc3 (1:200, a gift from H.D. Ryoo, New York University) 16 , and rabbit antibody to Dephrin (1:1,000, a gift from A.H. Brand, University of Cambridge) 54 . For detecting endogenous Hsc3 in the brain, or endogenous Meigo and overexpressed Ephrin in S2 cells, Can Get Signal solution A (TOYOBO) was used according to the manufacturer's instructions. Triple-labeling experiments with antibodies to mCD8 (rat), GFP (mouse) and Brp (mouse) (described above) were carried out with the Zenon Alexa Fluor 647 mouse IgG1 labeling kit (Molecular Probes), diluted in PBST.
Statistical analysis. Statistical tests were performed using Prism 5 (GraphPad Software). For the quantification of projection neuron dendrites and ORN axons, quantification of mRNA level of UPR target genes, and quantification of protein level of Ephrin-myc, Sema-1a and DN-cadherin, we used the Mann Whitney test. For quantification of the relative ratio of five bands in Figure 6d , we used two-way repeated-measures ANOVA and Bonferroni post-tests. The number of biologically independent experiments and P values are indicated in the figure legends. The sample sizes were chosen according to standard practice in the field.
Projection neuron phenotype quantification. For the quantification of projection neuron dendrites, we imaged the MARCM anterodorsal neuroblast clones labeled by GH146-Gal4 using an LSM5 PASCAL confocal microscope (Carl Zeiss) with an EC Plan-NEOFLUAR 40×/1,3 oil differential interference contrast lens (Carl Zeiss) and Immersol 518F (Carl Zeiss) immersion oil. The two-dimensional projection was derived from a confocal stack and dendrite termini were manually selected. The picture was rotated along the axis in question and a scale from 0 to 1 was overlaid, whereby the most medial or ventral corresponded to 0 and the most lateral or dorsal corresponded to 1 so as to maximally cover the antennal lobe. The relative amount of fluorescence along this scale was calculated. The mean positions of dendrite distribution were plotted as a graph and the average of the mean positions for each genetic manipulation was calculated. For the ORN axon quantification, the MARCM clones labeled by pebbled-Gal4 were imaged and calculated as above. Image processing was done using ImageJ (US National Institutes of Health). For DL1 projection neuron classification, the genotypes of the stacked images of the DL1 projection neurons were blinded to avoid experiment bias. The investigator who conducted the blind tests shown in Figures 1e, 4e and 5a and the investigator who conducted the blind test shown in Figure 6e were totally independent from the investigator who performed the experiments.
Identification of the meigo mutation. The MARCM-based mosaic screen and single-nucleotide polymorphism mapping methods leading to the identification of meigo 1 were analogous to those previously described 20 . Detailed mapping procedure is available on request.
Bioinformatics. For homology searches, we used InParanoid: Eukaryotic Ortholog Groups (http://inparanoid.sbc.su.se/cgi-bin/index.cgi). Identity and similarity were calculated by GENETYX-MAX. The Meigo structure was analyzed using the SOSUI server (http://bp.nuap.nagoya-u.ac.jp/sosui/). The proteins predicted to have NST activity were searched in Flybase (http://flybase.org/), and ClustalW (http://clustalw.ddbj.nig.ac.jp/top-j.html) was used to generate a phylogenetic tree of the putative Drosophila NSTs (Fig. 3). generation of meigo antibody. Monoclonal rat antibody to Meigo was generated by immunization with a synthetic KLH conjugated peptide (CVFAALFVDML YGKKAPLATAKKPPVEGKLSEEKKLNS) corresponding to the C terminus of Meigo (Hokudo). The antibodies were purified by affinity to the antigen peptides and used for immunostaining and western blot. dnA construction. To generate UAS-meigo, we obtained meigo cDNA from a cDNA library extracted from S2 cells. The meigo fragment was amplified using the following primers: 5′-CTTTAAAAACCGTCATCTGCCCG CC-3′ and 5′-GAAAATAAGTTGCCTTTGTTAGGC-3′. The PCR product was then subcloned into the pT7Blue vector by TA cloning. The fragment containing the entire cDNA was then cut from the vector using XbaI and KpnI and subcloned into the pUAST vector. To generate UAS shRNA for each gene, we followed a protocol 44 kindly provided by C.H. Chen (National Health Research Institute). The target sequences of the shRNAs are as follows: CG14511 shRNA (5′-GCCAGGGAAGCGTTGTATTACA-3′ and 5′-GTGCCCCTAATCCTGCTATACT-3′), Csat shRNA (5′-TTACTCG CACAGTGTTTTAAGA-3′ and 5′-AACGCCAATACGCTGAAGTACA-3′), CG14040 shRNA (5′-CAGCTGCAATCACATAATAAAA-3′ and 5′-GGGCA TACTATTCCAAATTATC-3′), ephrin shRNA (5′-AAGCAAGTTTCAA GGTTTTAAC-3′), eph shRNA (5′-GAACTCCGATGTAGATATTAAC-3′ and 5′-TAATGGATTTGGCTCTTATAGT-3′ and 5′-GGACCCACAAA CACAAATAATG-3′). Multiple sequences for a single gene means that multiple shRNAs are connected and subcloned into pUAST or pUAST-attB vectors. The mutant forms of UAS-ephrin-myc were generated using the QuickChange procedure (Stratagene). Primer sequences used for mutagenesis are available on request.
cell culture and transfection. S2 cells were grown at 26 °C in Schneider's medium supplemented with 10% heat-inactivated fetal bovine serum (vol/vol), 100 U ml −1 penicillin and 100 µg ml −1 streptomycin. Cells in six-well plates (1 × 10 6 cells per well) were transfected using the Effectene Transfection Reagent (Qiagen #301425) according to the manufacturer's instructions. We used 400 ng per well of Actin-Gal4 (pAcPa-Actin5c-GAL4) as a driver for each UAS transgene (400 ng per well for UASmeigo, 200 ng per well for UAS-Sema1a or UAS-DNcadherin (gift from T. Uemura, Kyoto University) and 100 ng per well for UAS-ephrin-myc). dsRnA treatment. Templates were generated by PCR amplification of the fulllength meigo and chloramphenicol acetyltransferase (cat) genes using 5′ and 3′ primers that contained T7 and T3 consensus site and gene sequences. dsRNA for bacterial cat was used as a negative control because it is not expressed in Drosophila S2 cells. The PCR fragments were then used as templates for in vitro transcription by T7 RNA polymerase or T3 RNA polymerase (Promega) for 2 h at 37 °C. The synthesized single-stranded RNA was then hybridized with singlestranded RNA of a complementary sequence to obtain the double-stranded RNA. For dsRNA treatment of S2 cells, the cells were plated in six-well plates (cell density, 10 6 cells per well). 30 mg of dsRNA were transfected using the Effectene Transfection Reagent (Qiagen #301425) for effective internalization of dsRNA,
